Barry S. Ticho

Barry Ticho MD, PhD is a highly accomplished professional with extensive experience in the biotechnology and pharmaceutical industry. Currently serving as the Chief Medical Officer at Stoke Therapeutics, Barry also holds advisory positions at Sania Therapeutics and Cardior Pharmaceuticals. Barry is the Founder and Board member at Verve Therapeutics, and has held key roles at companies such as Moderna Therapeutics, Pfizer, Biogen, and Merck. With a solid educational background from top institutions like Harvard Medical School and The University of Chicago Pritzker School of Medicine, Barry's expertise lies in clinical development and genetic medicines.